San Diego based OncoSec received the CE mark for its OncoSec Medical System (OMS) electroporation device. The OMS is used during chemotherapy and immunotherapy to open pores within the membranes of target cancer cells, making them more susceptible to injected compounds.
The system delivers short electric pulses via a stylus held by a physician, making it most practical for use in treating aggressive skin cancer. The company hopes that its technology will significantly improve the effectiveness of chemo and immunotherapies, reduce systemic toxicity, and lead to faster recovery for the patient.
Here’s a video describing OncoSec’s electroporation technology:
Press release: OncoSec Receives CE Mark for Its Electroporation Device
Product page: OncoSec Medical System…